• FirefoxInstall the new Firefox »
  •  Dow Up0.19% Nasdaq Up0.57%

    Teva Pharmaceutical Industries Limited (TEVA)

    -NYSE
    61.98 Down 0.44(0.70%) Mar 27, 4:02PM EDT
    |After Hours : 62.16 Up 0.18 (0.30%) Mar 27, 4:10PM EDT
    Add to Portfolio
    ProfileGet Profile for:
    Teva Pharmaceutical Industries Limited
    5 Basel Street
    Petach Tikva, 49131
    Israel - Map
    Phone: 972 3 926 7267
    Fax: 972 3 923 4050
    Website: http://www.tevapharm.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Drug Manufacturers - Other
    Full Time Employees:43,009

    Business Summary 

    Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic, specialty, and other pharmaceutical products worldwide. The company operates in two segments, Generic Medicines and Specialty Medicines. The Generic Medicines segment offers generic or branded generic medicines; specialized products, such as sterile products, hormones, narcotics, high-potency drugs, and cytotoxic substances; and active pharmaceutical ingredients. The Specialty Medicines segment provides branded specialty medicines for use in central nervous system and respiratory indications, as well as the women’s health, oncology, and other specialty businesses. Its products in the central nervous system area comprise Copaxone for multiple sclerosis; Azilect for the treatment of Parkinson’s disease; Nuvigil and Provigil to treat excessive sleepiness associated with narcolepsy, obstructive sleep apnea, and shift work disorders; Fentora/Effentora and Actiq to treat pain in opioid-tolerant adult patients with cancer; Zecuity for the treatment of migraine in adults; and Amrix for muscle spasm in acute, painful, and musculoskeletal conditions. This segment’s products in the respiratory market include ProAir, QVAR, and Duoresp Spiromax for the treatment of asthma and chronic obstructive pulmonary disease, as well as Treanda, Trisenox, Granix, Synribo, Lonquex, Tevagrastim/Ratiograstim, Myocet, and Eporatio products in the oncology market. This segment also offers a portfolio of products in the women’s health category, which includes ParaGard, Plan B One-Step, and Zoely. In addition, the company provides branded over-the-counter medicines in the categories of cough/cold and allergy, digestive wellness, vitamins, minerals and supplements, analgesics, and skin medications; and sells third-party products, such as medical devices and other miscellaneous items. Teva Pharmaceutical Industries Limited was founded in 1901 and is headquartered in Petach Tikva, Israel.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Teva Pharmaceutical Industries Limited

    Key Executives 
     PayExercised
    Mr. Erez Vigodman , 56
    Chief Exec. Officer, Pres, Director and Member of Fin. & Invesment Committee
    N/AN/A
    Mr. Eyal Desheh , 63
    Chief Financial Officer and Group Exec. VP
    N/AN/A
    Dr. Carlo De Notaristefani Ph.D., 57
    Chief Exec. Officer of Global Operations and Pres of Global Operations
    N/AN/A
    Dr. Michael R. Hayden CM, OBC, M.B. ChB., Ph.D., FRCP(C), FRSC, 63
    Chief Scientific Officer and Pres of Global R&D
    N/AN/A
    Mr. Richard S. Egosi , 52
    Chief Legal Officer and Group Exec. VP
    N/AN/A
    Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.